Speakers

Ellen Filvaroff

Executive Director in Translational Development

Bristol-Myers Squibb

Elisabetta Chiarparin

Director - Medicinal Chemistry

AstraZeneca

Zariana Nikolova

Executive Director

Bristol Myers Squibb

Sylvie Guichard

Senior Director - Translational Science & Biology

Forma Therapeutics

Drew Thompson

Vice President - Molecular Innovation & Pharmaceutical Development

Fulcrum Therapeutics

Chih-Ming Ho

Chief Technology Officer

KYAN Therapeutics

Johnathan R. Whetstine, PhD

Professor, Jack Schultz Basic Science Endowed Chair Director, Cancer Epigenetics Institute Program Co-leader Cancer Signaling and Epigenetics

Fox Chase Cancer Center

Kai He

Assistant Professor of Medicine

Ohio State University Comprehensive Cancer

James Winkler

Vice President - Biology & Translational Medicine

OnKure Inc.

Xuedong Liu

Chief Science Officer

OnKure Inc.

Tamara Maes

Founder, Shareholder, VP of Board of Directors, & President of Scientific Advisory Board

Oryzon Genomics

Robert Soliva

Head of Drug Discovery

Oryzon Genomics

Thomas Paul

Senior Director, Epigenetics Research

Pfizer

Aundrietta Duncan

Director, Non-Clinical Development

Salarius Pharmaceuticals

Alon Goren

Assistant Professor

University of California San Diego

Jiuzhou Song

Professor

University of Maryland

Antonello Mai

Professor

University of Rome La Sapienza

Nikhil Ghate

Postdoctoral Research Associate

University of Southern California

Laura Banaszynski

Principal Investigator

University of Texas Southwestern Medical Center

Ari Melnick

Professor

Weill Cornell - Cornell University